Therapeutic potential of vasculogenesis and osteogenesis promoted by peripheral blood CD34-positive cells for functional bone healing

American Journal of Pathology

Volumn 169, Issue 4, 2006, Pages 1440-1457

  Matsumoto, Tomoyuki ^a,b   Kawamoto, Atsuhiko ^a   Kuroda, Ryosuke ^b   Ishikawa, Masakazu ^a   Mifune, Yutaka ^a,b   Iwasaki, Hiroto ^a   Miwa, Masahiko ^b   Horii, Miki ^a   Hayashi, Saeko ^a   Oyamada, Akira ^a   Nishimura, Hiromi ^a   Murasawa, Satoshi ^a   Doita, Minoru ^b   Kurosaka, Masahiro ^b   Asahara, Takayuki ^a,c  

^a INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; ANGIOGENESIS INHIBITOR; MESSENGER RNA; OSTEOCALCIN;

ADULT; ANGIOGENESIS; ANIMAL CELL; ARTICLE; BIOMECHANICS; BONE DEVELOPMENT; CELL ISOLATION; CELL POPULATION; CELL SURFACE; CELL TRANSPLANTATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; FRACTURE; FRACTURE HEALING; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; CELL CULTURE; CELL MOTION; CHEMISTRY; DRUG EFFECT; FEMALE; FEMUR; FEMUR FRACTURE; GENETICS; NUDE RAT; PATHOLOGY; RAT; TRANSPLANTATION; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIGENS, CD34; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIAL CELLS; FEMALE; FEMORAL FRACTURES; FEMUR; GENE EXPRESSION; HUMANS; LEUKOCYTES, MONONUCLEAR; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOCALCIN; OSTEOGENESIS; RATS; RATS, NUDE; RNA, MESSENGER;

EID: 34047266512     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.060064     Document Type: Article

References (58)

1. Slack JM: Stem cells in epithelial tissues. Science 2000, 287:1431-1433
2. Blau HM, Brazelton TR, Weimann JM: The evolving concept of a stem cell: entity or function? Cell 2001, 105:829-841
3. Korbling M, Estrov Z: Adult stem cells for tissue repair - a new therapeutic concept? N Engl J Med 2003, 349:570-582
4. Weissman IL: Stem cells: units of development, units of regeneration, and units in evolution. Cell 2000, 100:157-168
5. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM: Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967
6. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM: Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999, 85:221-228
7. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T: Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999, 5:434-438
8. Kawamoto A, Tkebuchava T, Yamaguchi J, Nishimura H, Yoon YS, Milliken C, Uchida S, Masuo O, Iwaguro H, Ma H, Hanley A, Silver M, Kearney M, Losordo DW, Isner JM, Asahara T: Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 2003, 107:461-468
9. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, Itescu S: Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001, 7:430-436
10. Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S, Masuda H, Silver M, Ma H, Kearney M, Isner JM, Asahara T: Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001, 103:634-637
11. + cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 2004, 114:330-338
12. Rodriguez-Merchan EC, Forriol F: Nonunion: general principles and experimental data. Clin Orthop Relat Res 2004, (419):4-12
13. Marsh D: Concepts of fracture union, delayed union, and nonunion. Clin Orthop Relat Res 1998, (355 Suppl):S22-S30
14. Colnot CI, Helms JA: A molecular analysis of matrix remodeling and angiogenesis during long bone development. Mech Dev 2001, 100:245-250
15. Gerstenfeld LC, Cullinane DM, Barnes GL, Graves DT, Einhorn TA: Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 2003, 88:873-884
16. Karsenty G, Wagner EF: Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2002, 2:389-406
17. Long MW, Williams JL, Mann KG: Expression of human bone-related proteins in the hematopoietic microenvironment. J Clin Invest 1990, 86:1387-1395
18. Chen JL, Hunt P, McElvain M, Black T, Kaufman S, Choi ES: Osteoblast precursor cells are found in CD34+ cells from human bone marrow. Stem Cells 1997, 15:368-377
19. Tondreau T, Meuleman N, Delforge A, Dejeneffe M, Leroy R, Massy M, Mortier C, Bron D, Lagneaux L: Mesenchymal stem cells derive from CD133 positive cells in mobilized peripheral blood and cord blood: proliferation, Oct-4 expression and plasticity. Stem Cells 2005, 23:1105-1112
20. Ford JL, Robinson DE, Scammell BE: Endochondral ossification in fracture callus during long bone repair: the localisation of 'cavitylining cells' within the cartilage. J Orthop Res 2004, 22:368-375
21. Otani A, Kinder K, Ewalt K, Otero FJ, Schimmel P, Friedlander M: Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat Med 2002, 8:1004-1010
22. Rafii S, Lyden D: Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003, 9:702-712
23. Bonnarens F, Einhorn TA: Production of a standard closed fracture in laboratory animal bone. J Orthop Res 1984, 2:97-101
24. Kokubu T, Hak DJ, Hazelwood SJ, Reddi AH: Development of an atrophic nonunion model and comparison to a closed healing fracture in rat femur. J Orthop Res 2003, 21:503-510
25. Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, Li JJ, Sundaresan G, Wu AM, Gambhir SS, Weiss S: Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005, 307:538-544
26. Akerman ME, Chan WC, Laakkonen P, Bhatia SN, Ruoslahti E: Nanocrystal targeting in vivo. Proc Natl Acad Sci USA 2002, 99:12617-12621
27. Linden M, Sirsjo A, Lindbom L, Nilsson G, Gidlof A: Laser-Doppler perfusion imaging of microvascular blood flow in rabbit tenuissimus muscle. Am J Physiol 1995, 269:H1496-H1500
28. Wardell K, Jakobsson A, Nilsson GE: Laser Doppler perfusion imaging by dynamic light scattering. IEEE T Bio-Med Eng 1993, 40:309-316
29. Kendall RL, Thomas KA: Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA 1993, 90:10705-10709
30. Allen HL, Wase A, Bear WT: Indomethacin and aspirin: effect of nonsteroidal anti-inflammatory agents on the rate of fracture repair in the rat. Acta Orthop Scand 1980, 51:595-600
31. Hak DJ, Makino T, Niikura T, Hazelwood SJ, Curtiss S, Reddi AH: Recombinant human BMP-7 effectively prevents non-union in both young and old rats. J Orthop Res 2006, 24:11-20
32. Turner CH, Burr DB: Basic biomechanical measurements of bone: a tutorial. Bone 1993, 14:595-608
33. Peng Z, Tuukkanen J, Zhang H, Jamsa T, Vaananen HK: The mechanical strength of bone in different rat models of experimental osteoporosis. Bone 1994, 15:523-532
34. Makino T, Hak DJ, Hazelwood SJ, Curtiss S, Reddi AH: Prevention of atrophic nonunion development by recombinant human bone morphogenetic protein-7. J Orthop Res 2005, 23:632-638
35. Eghbali-Fatourechi G, Khosla S: Purification and characterization of circulating osteoblast lineage cells: expression of type1 collagen mRNA is a key difference between these and adherent bone marrow stromal cells. J Bone Miner Res 2005, 20:S12
36. Goodell MA, Rosenzweig M, Kim H, Marks DF, DeMaria M, Paradis G, Grupp SA, Sieff CA, Mulligan RC, Johnson RP: Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med 1997, 3:1337-1345
37. Dominici M, Pritchard C, Garlits JE, Hofmann TJ, Persons DA, Horwitz EM: Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation. Proc Natl Acad Sci USA 2004, 101:11761-11766
38. Olmsted-Davis EA, Gugala Z, Camargo F, Gannon FH, Jackson K, Kienstra KA, Shine HD, Lindsey RW, Hirschi KK, Goodell MA, Brenner MK, Davis AR: Primitive adult hematopoietic stem cells can function as osteoblast precursors. Proc Natl Acad Sci USA 2003, 100:15877-15882
39. Badorff C, Brandes RP, Popp R, Rupp S, Urbich C, Aicher A, Fleming I, Busse R, Zeiher AM, Dimmeler S: Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 2003, 107:1024-1032
40. Yeh ET, Zhang S, Wu HD, Korbling M, Willerson JT, Estrov Z: Trans-differentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation 2003, 108:2070-2073
41. Zhang S, Wang D, Estrov Z, Raj S, Willerson JT, Yeh ET: Both cell fusion and transdifferentiation account for the transformation of human peripheral blood CD34-positive cells into cardiomyocytes in vivo. Circulation 2004, 110:3803-3807
42. Iwasaki H, Kawamoto A, Ishikawa M, Oyamada A, Nakamori S, Nishimura H, Sadamoto K, Horii M, Matsumoto T, Murasawa S, Shibata T, Suehiro S, Asahara T: Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction. Circulation 2006, 113:1311-1325
43. Ratajczak MZ, Kucia M, Reca R, Majka M, Janowska-Wieczorek A, Ratajczak J: Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells 'hide out' in the bone marrow. Leukemia 2004, 18:29-40
44. Kucia M, Dawn B, Hunt G, Guo Y, Wysoczynski M, Majka M, Ratajczak J, Rezzoug F, Ildstad ST, Bolli R, Ratajczak MZ: Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction. Circ Res 2004, 95:1191-1199
45. Eghbali-Fatourechi GZ, Lamsam J, Fraser D, Nagel D, Riggs BL, Khosla S: Circulating osteoblast-lineage cells in humans. N Engl J Med 2005, 352:1959-1966
46. Majka M, Janowska-Wieczorek A, Ratajczak J, Ehrenman K, Pietrzkowski Z, Kowalska MA, Gewirtz AM, Emerson SG, Ratajczak MZ: Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/ paracrine manner. Blood 2001, 97:3075-3085
47. Janowska-Wieczorek A, Majka M, Ratajczak J, Ratajczak MZ: Autocrine/ paracrine mechanisms in human hematopoiesis. Stem Cells 2001, 19:99-107
48. Taichman RS: Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche. Blood 2005, 105:2631-2639
49. Zhu J, Emerson SG: A new bone to pick: osteoblasts and the haematopoietic stem-cell niche. Bioessays 2004, 26:595-599
50. Zhang J, Niu C, Ye L, Huang H, He X, Tong WG, Ross J, Haug J, Johnson T, Feng JQ, Harris S, Wiedemann LM, Mishina Y, Li L: Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003, 425:836-841
51. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, Martin RP, Schipani E, Divieti P, Bringhurst FR, Milner LA, Kronenberg HM, Scadden DT: Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003, 425:841-846
52. Ponomaryov T, Peled A, Petit I, Taichman RS, Habler L, Sandbank J, Arenzana-Seisdedos F, Magerus A, Caruz A, Fujii N, Nagler A, Lahav M, Szyper-Kravitz M, Zipori D, Lapidot T: Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J Clin Invest 2000, 106:1331-1339
53. Quarto R, Mastrogiacomo M, Cancedda R, Kutepov SM, Mukhachev V, Lavroukov A, Kon E, Marcacci M: Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 2001, 344:385-386
54. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, Sussman M, Orchard P, Marx JC, Pyeritz RE, Brenner MK: Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999, 5:309-313
55. Petite H, Viateau V, Bensaid W, Meunier A, de Pollak C, Bourguignon M, Oudina K, Sedel L, Guillemin G: Tissue-engineered bone regeneration. Nat Biotechnol 2000, 18:959-963
56. Wakitani S, Imoto K, Yamamoto T, Saito M, Murata N, Yoneda M: Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthr Cartilage 2002, 10:199-206
57. Brugger W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L: Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo.[see comment] [retraction in Kanz L, Brugger W: N Engl J Med 2001 Jul 5;345(1):64; PMID: 11439953]. N Engl J Med 1995, 333:283-287
58. Kessinger A, Armitage JO: The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood 1991, 77:211-213